Aspects of HIV-therapy in pregnancy;Aspekte der HIV-therapie in der schwangerschaft

Gynakologe

Volumn 38, Issue 8, 2005, Pages 694-700

  Krosigk, A V ^a,b   Jager H ^a  

^a Gemeinschaftspraxis   (Germany)

^b Gemeinschaftspraxis fur Dermatol   (Germany)

Author keywords

HIV infection; HIV transmission prophylaxis; Materno fetal transmission; Pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL ACTIVITY; CESAREAN SECTION; ELECTIVE SURGERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PATIENT COUNSELING; PATIENT MONITORING; PLACENTAL TRANSFER; PREGNANCY; PREGNANT WOMAN; REVIEW; VERTICAL TRANSMISSION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 24344471072     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-005-1715-z     Document Type: Review

References (18)

1. Thorne C, Newell ML (2003) Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues. Med Wieku Rozwoj 7: 425-436
2. Robert Koch Institut (2004) HIV/AIDS-Quartalsberichte, 4/2004
3. Perinatal HIV-1 Guidelines Working Group (2004) Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 Transmission in the United States. Public Health Service Task Force
4. British HIV Association (2005) Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV
5. Deutsche AIDS-Gesellschaft (DAIG) Österreichisch AIDS Gesellschaft (ÖAG), Kompetenznetz HIV/ AIDS et al. (2003) Deutsch-Österreichische Empfehlungen zur HIV-Therapie in der Schwangerschaft. AWMF-Leitlinien-Register (Nr. 055/002): 1-16
6. Cooper ER, Charurat M, Mofenson L et al.; Women and Infants' Transmission Study Group (2002) Combination antiretroviral strategies for treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Sydnr 29: 489-494
7. Hart CE, Lennox JL, Pratt-Palmore M et al. (1999) Correlation of human immunodeficiency virus typelRNA levels in blood and the female genital tract. J Infect Dis 179: 871-882
8. Connor EM, Sperling RS, Gelber R et al. (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with ZDV treatment. N Engl J Med 331: 1173-1180
9. Bogner J, Grubert T (2003) HIV und Schwangerschaft. Uni-Med, Bremen
10. Eastman PS, Shapiro DE, Coombs RW et al. (1998) Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinicl Trial Group Protocol 076. J Infect Dis 177: 557-564
11. Lallemant M, Jourdain G, Le Coeur S et al. (2000) A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. N Engl J Med 343: 982-991
12. Shaffer N, Chuachoowong R, Mock PA et al. (1999) Short-course ziduvodine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353: 773-780
13. Dorenbaum A et al. for the PACTAG316 Study Team (2001) Report of results of PACTAG316: An international Phase III trial of Standart Antiretroviral (ARV) prophylaxis plus nevirapine(NVP) for prevention of perinatal HIV transmission. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA
14. Schäfer C (1997) Arzneimitteltherapie in der Schwangerschaft. In: Jäger C (Hrsg) AIDS und HIV-Infektionen, 20. Erg. Lfg. 3: V-5.1
15. Ioannidis JP, Abrams EJ, Ammann A et al. (2001) Perinatal transmission of human immunodeficiency virus type 1 by pregnant woman with RNA virus loads <1000 copies/ml. J Infect Dis 183: 539-545
16. Culnane M, Fowler M, Lee SS et al. (1999) Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 281: 151-157
17. Meyohas MC, Lacombe K, Carbonne B, Morand-Joubert L, Girard PM (2004) Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. AIDS 18: 1966-1967
18. Quay LA, Musoke P, Fleming T et al. (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354: 795-802